Source: FinanzNachrichten

Abzena: Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies

Biopharma gains a seamless transition from drug discovery through drug product manufacturing SAN DIEGO, June 20, 2024 /PRNewswire/ -- Abzena, the leading end-to-end integrated contract and develop...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Matthew Stober's photo - CEO of Abzena

CEO

Matthew Stober

CEO Approval Rating

82/100

Read more